Friday, July 10, 2026

pharma · Not applicable, healthy volunteers · ulcerative pyoderma gangrenosum

InflaRx

InflaRx patent portfolio — 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Jena, DE HQ
2007 Founded
52 Employees
EMA registrant Type
Company details
Status
Public
HQ
Jena, DE
Founded
2007
Employees
52
Programs
4
Drugs
20
Patents
0
Intelligence · Patents

InflaRx patents

0 pharmaceutical patents indexed for InflaRx. 0 expire within 24 months.

InflaRx has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does InflaRx have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do InflaRx patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.